UniProt ID | TERT_HUMAN | |
---|---|---|
UniProt AC | O14746 | |
Protein Name | Telomerase reverse transcriptase | |
Gene Name | TERT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1132 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm. Nucleus. Chromosome, telomere. Cytoplasm. Nucleus, PML body. Shuttling between nuclear and cytoplasm depends on cell cycle, phosphorylation states, transformation and DNA damage. Diffuse localization in the | |
Protein Description | Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-dependent extension of 3'-chromosomal termini with the 6-nucleotide telomeric repeat unit, 5'-TTAGGG-3'. The catalytic cycle involves primer binding, primer extension and release of product once the template boundary has been reached or nascent product translocation followed by further extension. More active on substrates containing 2 or 3 telomeric repeats. Telomerase activity is regulated by a number of factors including telomerase complex-associated proteins, chaperones and polypeptide modifiers. Modulates Wnt signaling. Plays important roles in aging and antiapoptosis.. | |
Protein Sequence | MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQGWRLVQRGDPAAFRALVAQCLVCVPWDARPPPAAPSFRQVSCLKELVARVLQRLCERGAKNVLAFGFALLDGARGGPPEAFTTSVRSYLPNTVTDALRGSGAWGLLLRRVGDDVLVHLLARCALFVLVAPSCAYQVCGPPLYQLGAATQARPPPHASGPRRRLGCERAWNHSVREAGVPLGLPAPGARRRGGSASRSLPLPKRPRRGAAPEPERTPVGQGSWAHPGRTRGPSDRGFCVVSPARPAEEATSLEGALSGTRHSHPSVGRQHHAGPPSTSRPPRPWDTPCPPVYAETKHFLYSSGDKEQLRPSFLLSSLRPSLTGARRLVETIFLGSRPWMPGTPRRLPRLPQRYWQMRPLFLELLGNHAQCPYGVLLKTHCPLRAAVTPAAGVCAREKPQGSVAAPEEEDTDPRRLVQLLRQHSSPWQVYGFVRACLRRLVPPGLWGSRHNERRFLRNTKKFISLGKHAKLSLQELTWKMSVRDCAWLRRSPGVGCVPAAEHRLREEILAKFLHWLMSVYVVELLRSFFYVTETTFQKNRLFFYRKSVWSKLQSIGIRQHLKRVQLRELSEAEVRQHREARPALLTSRLRFIPKPDGLRPIVNMDYVVGARTFRREKRAERLTSRVKALFSVLNYERARRPGLLGASVLGLDDIHRAWRTFVLRVRAQDPPPELYFVKVDVTGAYDTIPQDRLTEVIASIIKPQNTYCVRRYAVVQKAAHGHVRKAFKSHVSTLTDLQPYMRQFVAHLQETSPLRDAVVIEQSSSLNEASSGLFDVFLRFMCHHAVRIRGKSYVQCQGIPQGSILSTLLCSLCYGDMENKLFAGIRRDGLLLRLVDDFLLVTPHLTHAKTFLRTLVRGVPEYGCVVNLRKTVVNFPVEDEALGGTAFVQMPAHGLFPWCGLLLDTRTLEVQSDYSSYARTSIRASLTFNRGFKAGRNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLLKLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALEAAANPALPSDFKTILD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | Phosphorylation | REVLPLATFVRRLGP HHHHHHHHHHHHHCH | 30.28 | - | |
122 | Phosphorylation | FTTSVRSYLPNTVTD HHHHHHHHCCCHHHH | 18.66 | - | |
134 | Phosphorylation | VTDALRGSGAWGLLL HHHHHHCCCHHHHHH | 20.92 | - | |
227 | Phosphorylation | GARRRGGSASRSLPL CCCCCCCCCCCCCCC | 26.37 | 22366458 | |
249 | Phosphorylation | AAPEPERTPVGQGSW CCCCCCCCCCCCCCC | 22.21 | - | |
283 | Phosphorylation | ARPAEEATSLEGALS CCCHHHHCCCCHHHC | 36.80 | 22210691 | |
284 | Phosphorylation | RPAEEATSLEGALSG CCHHHHCCCCHHHCC | 31.32 | 22210691 | |
344 | Phosphorylation | DKEQLRPSFLLSSLR CHHHHCHHHHHHHCC | 23.30 | 30622161 | |
348 | Phosphorylation | LRPSFLLSSLRPSLT HCHHHHHHHCCHHHC | 29.49 | 17081983 | |
349 | Phosphorylation | RPSFLLSSLRPSLTG CHHHHHHHCCHHHCH | 28.50 | 25954137 | |
353 | Phosphorylation | LLSSLRPSLTGARRL HHHHCCHHHCHHHHH | 31.93 | 24719451 | |
457 | Phosphorylation | QLLRQHSSPWQVYGF HHHHHCCCHHHHHHH | 28.21 | 23362280 | |
480 | Phosphorylation | VPPGLWGSRHNERRF CCCCCCCCCHHHHHH | 20.84 | 24719451 | |
618 | Phosphorylation | EARPALLTSRLRFIP HHHHHHHHHCEEECC | 16.79 | 24719451 | |
679 | Phosphorylation | RPGLLGASVLGLDDI CCCCCCCHHCCHHHH | 18.97 | 27251275 | |
692 | Phosphorylation | DIHRAWRTFVLRVRA HHHHHHHHEEEEEEE | 13.85 | 27251275 | |
707 | Phosphorylation | QDPPPELYFVKVDVT CCCCCCEEEEEEECC | 12.50 | 16627250 | |
707 (in isoform 4) | Phosphorylation | - | 12.50 | 12808100 | |
731 | Phosphorylation | RLTEVIASIIKPQNT HHHHHHHHHHCCCCC | 17.45 | 24719451 | |
767 | Phosphorylation | KSHVSTLTDLQPYMR HHHCCHHHHCHHHHH | 34.45 | - | |
785 (in isoform 4) | Phosphorylation | - | 38.54 | - | |
797 (in isoform 2) | Phosphorylation | - | 40.22 | - | |
797 | Phosphorylation | VVIEQSSSLNEASSG EEEECCCCCCHHHHC | 40.22 | 16565220 | |
824 | Phosphorylation | AVRIRGKSYVQCQGI HHHHCCCCEEECCCC | 33.10 | 22817900 | |
948 | Phosphorylation | EVQSDYSSYARTSIR EECCCCHHHCHHCHH | 19.31 | - | |
949 | Phosphorylation | VQSDYSSYARTSIRA ECCCCHHHCHHCHHE | 8.31 | - | |
984 | Phosphorylation | VLRLKCHSLFLDLQV HHHHHHHHHHHHCCC | 30.22 | - | |
1045 | Phosphorylation | DTASLCYSILKAKNA CHHHHHHHHHHHHHC | 22.05 | 24719451 | |
1059 | Acetylation | AGMSLGAKGAAGPLP CCCCCCCCCCCCCCC | 47.48 | 30592905 | |
1095 | Phosphorylation | TYVPLLGSLRTAQTQ CHHHHHHHHHHHHHH | 18.04 | 24719451 | |
1101 | Phosphorylation | GSLRTAQTQLSRKLP HHHHHHHHHHHHCCC | 29.07 | 16094384 | |
1113 | Phosphorylation | KLPGTTLTALEAAAN CCCCCHHHHHHHHHC | 27.40 | 16094384 | |
1125 | Phosphorylation | AANPALPSDFKTILD HHCCCCCCCCCHHCC | 57.43 | 16094384 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
227 | S | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
227 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
227 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
249 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
457 | S | Phosphorylation | Kinase | DYRK2 | Q92630 | Uniprot |
707 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
707 | Y | Phosphorylation | Kinase | SRC-FAMILY | - | GPS |
707 | Y | Phosphorylation | Kinase | SRC-TYPE TYR-KINASES | - | Uniprot |
707 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
824 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
824 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
824 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:20453884 |
- | K | Ubiquitination | E3 ubiquitin ligase | DYRK2 | Q92630 | PMID:23362280 |
- | K | Ubiquitination | E3 ubiquitin ligase | MKRN1 | Q9UHC7 | PMID:15805468 |
- | K | Ubiquitination | E3 ubiquitin ligase | DCAF1 | Q9Y4B6 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TERT_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
Note=Activation of telomerase has been implicated in cell immortalization and cancer cell pathogenesis. | |
609135 | |
Note=Genetic variations in TERT are associated with coronary artery disease (CAD). | |
613989 | |
614742 | Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 1 (PFBMFT1) |
613989 | Dyskeratosis congenita, autosomal recessive, 4 (DKCB4) |
178500 | Pulmonary fibrosis, idiopathic (IPF) |
615134 | Melanoma, cutaneous malignant 9 (CMM9) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00495 | Zidovudine |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1113 AND SER-1125, ANDMASS SPECTROMETRY. | |
"Nuclear protein tyrosine phosphatase Shp-2 is one important negativeregulator of nuclear export of telomerase reverse transcriptase."; Jakob S., Schroeder P., Lukosz M., Buchner N., Spyridopoulos I.,Altschmied J., Haendeler J.; J. Biol. Chem. 283:33155-33161(2008). Cited for: INTERACTION WITH PTPN11, PHOSPHORYLATION AT TYR-707, SUBCELLULARLOCATION, AND MUTAGENESIS OF TYR-707. | |
"Hydrogen peroxide triggers nuclear export of telomerase reversetranscriptase via Src kinase family-dependent phosphorylation oftyrosine 707."; Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., Dimmeler S.; Mol. Cell. Biol. 23:4598-4610(2003). Cited for: PHOSPHORYLATION AT TYR-707, SUBCELLULAR LOCATION, INTERACTION WITH RANAND XP01, AND MUTAGENESIS OF TYR-707. |